When Congress created the program, it explicitly excluded coverage for drugs associated with weight loss or gain
Second, the administration said that 10% of Medicare recipients would newly qualify for a GLP-1 based on their criteria
In addition, the astrocytic glutamine synthetase will convert ammonia and glutamate into glutamine, which in turn acts as an osmolyte and will increase cerebral volume [8]
Injectable GLP-1 therapies tend to produce greater weight loss, but many patients prefer the consistency and convenience of a pill they can actually take every day
And yet, some healthcare providers are recommending it, compounding pharmacies are filling prescriptions for it, and online communities are full of people who swear by it
They do not constitute clinical evidence of efficacy or safety in humans, and all reference to biological activity pertains strictly to preclinical research settings